Trial Profile

A Phase 1/2, double blind, placebo-controlled trial of JadiCells in advanced COVID-19 patients

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 12 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Allogeneic umbilical cord mesenchymal stem cells-Therapeutic Solutions International (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

05 Aug 2021 Results presented in the Therapeutic Solutions International Media Release
10 Feb 2021 Status changed from recruiting to completed, according to a Therapeutic Solutions International media release.
27 Jan 2021 Results published in Creative Medical Technology Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com